Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA revision/version label at the bottom of the page was updated from v3.5.2 to v3.5.3. This represents a change in the site’s release version rather than any modification to the clinical study details.SummaryDifference0.1%

- Check15 days agoChange DetectedFooter revision tag updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe page now displays a new revision note, v3.5.0, and the previous revision note, v3.4.3, was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded Revision: v3.4.2 tag; removed the prior funding/operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check86 days agoChange DetectedSite-wide notice about funding and data currency has been added, indicating the NIH Clinical Center is open and where to find operating status updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.